
Nutra Pharma Announces First Manufacturing Agreement
Nutra Pharma is announcing Avini Health as its first contract manufacturing partner. March 23, 2022 -- Plantation, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Equine Pain-Away™ and Luxury Feet™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, is announcing their first agreement to act as a produc

Nutra Pharma Expands Manufacturing Capabilities
Nutra Pharma is providing updates on their work in improving manufacturing scale and capabilities for new product launches for their OTC drugs and potential dietary supplements. March 17, 2022 -- Plantation, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Equine Pain-Away™ and Luxury Feet™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human